SITC Archive Library

2017-2018 Advances in Cancer Immunotherapy™ Post Program Webinar Series - Boston Webinar 1 

08-28-2019 09:46

From the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) post-program webinar recording for the 2017 Boston event is provided here. The purpose of this webinar series is to help attendees of the ACI program stay connected with regional experts, ask questions and receive guidance from program organizers.

Webinar Faculty:

  • David McDermott, MD – Beth Israel Deaconess Medical Center
  • Virginia Seery, MSN, RN, ANP-BC – Beth Israel Deaconess Medical Center

This webinar focused on irAE management and addressed the following questions:
  • Will toxicity management prove challenging?
  • Will rare but serious toxicities occur?
  • Will late toxicity emerge?
  • Will certain toxicities make combinations difficult?
  • Will history of autoimmune limit application?
  • What are side effects of immunotherapy that require immediate attention?
  • How often do you see cardiac toxicity?
  • Do you run baseline labs such as cortisol prior to initiating immunotherapy?
  • What roles can a RN play in advancing and promoting the use of immunotherapy?

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, scroll down to view Related Entries and Links.

#RecordedWebinar#AdvancesinCancerImmunotherapy(ACI)#Toxicities
#AdverseEvents#SITC#CombinationTherapy#ImmuneCheckpointInhibitors
#Clinician#RegisteredNurse#Oncologist#Pharmacist#PrimaryCarePhysician
#2017

Statistics
0 Favorited
26 Views
1 Files
0 Shares
16 Downloads